249 related articles for article (PubMed ID: 20309872)
1. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes.
Mahmoodi M; Aliabadi A; Emami S; Safavi M; Rajabalian S; Mohagheghi MA; Khoshzaban A; Samzadeh-Kermani A; Lamei N; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2010 Jul; 343(7):411-6. PubMed ID: 20309872
[TBL] [Abstract][Full Text] [Related]
2. 2-Amino-3-cyano-4-(5-arylisoxazol-3-yl)-4H-chromenes: synthesis and in vitro cytotoxic activity.
Akbarzadeh T; Rafinejad A; Mollaghasem JM; Safavi M; Fallah-Tafti A; Pordeli M; Ardestani SK; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2012 May; 345(5):386-92. PubMed ID: 22266847
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions.
Kemnitzer W; Kasibhatla S; Jiang S; Zhang H; Zhao J; Jia S; Xu L; Crogan-Grundy C; Denis R; Barriault N; Vaillancourt L; Charron S; Dodd J; Attardo G; Labrecque D; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2005 Nov; 15(21):4745-51. PubMed ID: 16143530
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Crogan-Grundy C; Labreque D; Bubenick M; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2008 Feb; 51(3):417-23. PubMed ID: 18197614
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay.
Kemnitzer W; Jiang S; Zhang H; Kasibhatla S; Crogan-Grundy C; Blais C; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2008 Oct; 18(20):5571-5. PubMed ID: 18805007
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells.
Chandrappa S; Kavitha CV; Shahabuddin MS; Vinaya K; Ananda Kumar CS; Ranganatha SR; Raghavan SC; Rangappa KS
Bioorg Med Chem; 2009 Mar; 17(6):2576-84. PubMed ID: 19243955
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel chromene derivatives of expected antitumor activity.
Kandeel MM; Kamal AM; Abdelall EK; Elshemy HA
Eur J Med Chem; 2013 Jan; 59():183-93. PubMed ID: 23220647
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activities of N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives.
Lou J; Liu Z; Li Y; Zhou M; Zhang Z; Zheng S; Wang R; Li J
Bioorg Med Chem Lett; 2011 Nov; 21(22):6662-6. PubMed ID: 21986587
[TBL] [Abstract][Full Text] [Related]
16. Chromenes: potential new chemotherapeutic agents for cancer.
Patil SA; Patil R; Pfeffer LM; Miller DD
Future Med Chem; 2013 Sep; 5(14):1647-60. PubMed ID: 24047270
[TBL] [Abstract][Full Text] [Related]
17. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
Nguyen TM; Sittisombut C; Boutefnouchet S; Lallemand MC; Michel S; Koch M; Tillequin F; Mazinghien R; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A
J Med Chem; 2006 Jun; 49(11):3383-94. PubMed ID: 16722658
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]